| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +22.8K | 100% | $7.45 | +$170K |
| Sells | 0 | ||||
| Net | +3 | +22.8K | 100% | +$170K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Hing C. Wong | Chief Executive Officer, Director, 10%+ Owner | $3.74M | +$60K | +1.63% | May 16, 2025 |
| Scott T. Garrett | Director | $190K | +$100K | +111% | May 16, 2025 |
| Peter Rhode | Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. | $161K | Dec 11, 2023 | ||
| Jin-an Jiao | VP of Development | $93.8K | May 31, 2022 | ||
| Lisa M. Giles | Director | $50.1K | Jun 14, 2024 | ||
| Gary M. Winer | Director | $30.4K | +$10K | +49.1% | May 16, 2025 |
| Rebecca Byam | Chief Financial Officer | $10.3K | May 7, 2025 | ||
| Lee Flowers | SVP of Business Development | $1.37K | May 7, 2025 | ||
| Rick S. Greene | Director | $495 | May 7, 2025 | ||
| Medmira Capital Ltd. | 10%+ Owner | Sep 15, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|